Apr 18 |
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
|
Apr 17 |
ABVC BioPharma executes licensing agreement with OncoX
|
Apr 17 |
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
|
Apr 10 |
ABVC Biopharma stock climbs on deal for its oncology/hematology products
|
Apr 10 |
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
|
Mar 26 |
Why ABVC BioPharma Stock Is Up Today
|
Mar 26 |
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
|
Mar 21 |
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
|
Mar 14 |
ABVC BioPharma GAAP EPS of -$2.43, revenue of $0.15M
|
Mar 14 |
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
|